Efficacy of Gefapixant, a P2X(3) Antagonist, for Refractory Atopic Cough

Cough, a frequent symptom encountered in clinical practice, often has a considerable impact on patients’ lives. There is an urgent need to investigate more potent antitussive treatments for chronic refractory cough, particularly atopic cough, which is a major cause of chronic refractory cough in Jap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishiura, Yoshihisa, Nomura, Shosaku, Ishii, Yuka, Imai, Kai, Sawai, Yusuke, Tamaki, Takeshi, Shimizu, Toshiki, Miyashita, Naoyuki, Ito, Tomoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487696/
https://www.ncbi.nlm.nih.gov/pubmed/37692174
http://dx.doi.org/10.2147/IMCRJ.S427098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487696/
https://www.ncbi.nlm.nih.gov/pubmed/37692174
http://dx.doi.org/10.2147/IMCRJ.S427098

Ejemplares similares